A method to avoid errors associated with the analysis of hypermutated viral sequences by alignment-based methods

The human genome encodes for a family of editing enzymes known as APOBEC3 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like3). They induce context dependent G-to-A changes, referred to as "hypermutation", in the genome of viruses such as HIV, SIV, HBV and endogenous retroviruses. Hypermutation is characterized by aligning affected sequences to a reference sequence. We show that indels (insertions/deletions) in the sequences lead to an incorrect assignment of APOBEC3 targeted and non-target sites. This can result in an incorrect identification of hypermutated sequences and erroneous biological inferences made based on hypermutation analysis.

[1]  R. Fisher.  Statistical methods for research workers , 1927, Protoplasma.

[2]  R. Fisher,et al.  Statistical Methods for Research Workers. , 1955 .

[3]  F. Hecht,et al.  HIV-1 Vif adaptation to human APOBEC3H haplotypes. , 2013, Cell host & microbe.

[4]  L. Loh,et al.  Control of Viremia and Prevention of AIDS following Immunotherapy of SIV-Infected Macaques with Peptide-Pulsed Blood , 2008, PLoS pathogens.

[5]  V. Simon,et al.  The Resistance of Human APOBEC3H to HIV-1 NL4-3 Molecular Clone Is Determined by a Single Amino Acid in Vif , 2013, PloS one.

[6]  J. Coffin,et al.  Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses , 2007, PLoS genetics.

[7]  Rebecca Batorsky,et al.  Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection , 2011, Proceedings of the National Academy of Sciences.

[8]  C. Moore,et al.  Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation , 2006, Journal of Virology.

[9]  W. Greene,et al.  The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. , 2008, Annual review of immunology.

[10]  M. Malim,et al.  APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation , 2007, Journal of Biological Chemistry.

[11]  V. Pathak,et al.  Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Lela Lackey,et al.  Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1 , 2011, Journal of Virology.

[13]  L. Loh,et al.  An “Escape Clock” for Estimating the Turnover of SIV DNA in Resting CD4+ T Cells , 2012, PLoS pathogens.

[14]  B. Levin,et al.  Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections , 2004, Antimicrobial Agents and Chemotherapy.

[15]  M. Davenport,et al.  Insights into the Motif Preference of APOBEC3 Enzymes , 2014, PloS one.

[16]  Xiaojun Wang,et al.  Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity , 2011, Journal of Virology.

[17]  Susan P. Holmes,et al.  A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing reads , 2010, Bioinform..

[18]  John J. Welch,et al.  Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences , 2008, Journal of Virology.

[19]  M. Muramatsu,et al.  Uracil DNA Glycosylase Counteracts APOBEC3G-Induced Hypermutation of Hepatitis B Viral Genomes: Excision Repair of Covalently Closed Circular DNA , 2013, PLoS pathogens.

[20]  W. Brown,et al.  APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo , 2004, Current Biology.

[21]  K. Strebel,et al.  HIV-1 Vif, APOBEC, and Intrinsic Immunity , 2008, Retrovirology.

[22]  S. Mboup,et al.  The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals. , 2008, AIDS research and human retroviruses.

[23]  Gersende Caron,et al.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.

[24]  Bette T. Korber,et al.  Detecting hypermutations in viral sequences with an emphasis on G A hypermutation , 2000, Bioinform..

[25]  Reuben S. Harris,et al.  Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.